1 study found for:    23782157 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of PCI-32765 in Subjects With Relapsed/Refractory Mantle Cell Lymphoma (MCL)
Condition: Mantle Cell Lymphoma
Intervention: Drug: PCI-32765

Indicates status has not been verified in more than two years